
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Date: February 08 - February 12, 2015
Description:
Topic: Focus on Small Animal Ophthalmology and GastroenterologySpeakers: Dr. David Wilkie and Dr. Jane Armstrong15 CE hours
Event Address: Hilton Whistler Resort
For More Information:,ContinuEd
Post Office Box 75598 ,Seattle ,Washington ,98175-0598 ,United States
800-539-7395, [email protected], www.continu-ed.com





